Health CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma Posted on March 24, 2024 by miyuru For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-specific antigen, in addition to the wild-type….
